AskVantage

Opnovix

Opnovix is a startup headquartered in Palo Alto, United States, founded in 2019. It has raised at least $5.3m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.

Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .

2019Founded
StartupStage
Palo Alto, United StatesHeadquarters
TechnologyIndustry
$5.3m+Raised (SEC filings)
EarlyFunding stage
Technology
See it on the interactive mapBook a Briefing

Funding

Opnovix has raised at least $5.3m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.

R&D ecosystem

Opnovix sits inside the Silicon Valley and the Bay Area R&D ecosystem in the Global R&D Labs Directory.

Other startups in Palo Alto

Related

Questions and answers

What does Opnovix do?

Opnovix is classed in technology in its filings with the US Securities and Exchange Commission.

How much has Opnovix raised?

At least $5.3m, according to its Form D filings with the US Securities and Exchange Commission.

Where is Opnovix based?

Opnovix is headquartered in Palo Alto, United States.

When was Opnovix founded?

Opnovix was founded in 2019.

Source record: SEC EDGAR (Form D filings).

© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.